Abnormal expression of JUNB gene in hepatocellular carcinoma

Oncology Reports

Volumn 13, Issue 3, 2005, Pages 433-438

  Chang, Ya Sian ^a   Yeh, Kun Tu ^b   Yang, Ming Yu ^c   Liu, Ta Chih ^c   Lin, Sheng Fung ^c   Chan, Wen Ling ^a   Chang, Jan Gowth ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Taipei Institute of Pathology   (Taiwan)

Author keywords

Expression; Human hepatocellular carcinoma; JUNB; Methylation

Indexed keywords

PROTEIN P16INK4A;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; ONCOGENE; PATHOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENES, JUN; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 15044361936     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.3.433     Document Type: Article

References (36)

1. Eferl R and Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003. (Pubitemid 37383716)
2. Angel P and Karin M: The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991. (Pubitemid 121007534)
3. Mechta-Grigoriou F, Gerald D and Yaniv M: The mammalian Jun proteins: redundancy and specificity. Oncogene 20: 2378-2389, 2001. (Pubitemid 32531296)
4. Lord KA, Hoffman-Liegermann B and Liebermann DA: Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, junB, and nistone variants. Oncogene 5: 387-396, 1990.
5. Boise LH, Petryniak B, Mao X, et al: The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and junB. Mol Cell Biol 13: 1911-1919, 1993. (Pubitemid 23068131)
6. Hsu JC, Bravo R and Taub R: Interaction among LRF-1, junB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 12: 4654-4665, 1992.
7. Saffen DW, Cole AJ, Worley PF, Christy BA, Ryder K and Baraban JM: Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc Natl Acad Sci USA 85: 7795-7799, 1998.
8. Ryder K, Lau LF and Nathans D: A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci USA 85: 1487-1491, 1988. (Pubitemid 18070796)
9. Wilkinson DG, Bhatt S, Ryseck RP and Bravo R: Tissue-specific expression of c-jun and jun-B during organogenesis in the mouse. Dev 106: 465-471, 1989. (Pubitemid 19195221)
10. Chiu R, Angel P and Karin M: Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59: 979-986, 1989. (Pubitemid 20024609)
11. Hsu JC, Cressman DE and Taub R: Promoter-specific transactivation and inhibition mediated by JunB. Cancer Res 53: 3789-3794, 1993. (Pubitemid 23252044)
12. Schütte, Viallet J, Nau M, Segal S, Fedorko J and Minna J: jun-B inhibits and c-fos stimulates the transforming and transactivating activities of c-jun. Cell 59: 987-997, 1989.
13. Passegné E, Jochum W, Behrens A, Ricci R and Wagner EF: JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet 30: 158-166, 2002.
14. Schorpp-Kistner M, Wang ZQ, Angel P and Wagner EF: JunB is essential for mammalian placentation. EMBO J 18: 934-948, 1999. (Pubitemid 29082273)
15. Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiner H and Angel P: The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 24: 1787-1788, 1996. (Pubitemid 26137941)
16. Passegué E and Wanger EF: JunB suppresses cell proliferation by transcriptional activation of p16INK4aexpression. EMBO J 19: 2969-2979, 2000. (Pubitemid 30386768)
17. Bakiri Latifa, Lallemand D, Bossy-Wetzel E and Yaniv M: Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19: 2056-2068, 2000. (Pubitemid 30237581)
18. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF: Control of cell cycle pro-gression by c-Jun is p53 dependent. Gene Dev 13: 607-619, 1999. (Pubitemid 29131884)
19. Bosch FX, Ribes J and Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285, 1999. (Pubitemid 29488770)
20. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J and Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene 21: 2593-2604, 2002. (Pubitemid 34438112)
21. Thorgeirrson S and Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346, 2002.
22. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ and Kang GH: Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163: 1371-1378, 2003. (Pubitemid 37175085)
23. Matsuda Y, Ichida T, Genda T, Yamagiwa S, Aoyagi Y and Asakura H: Loss of P16 contributes to P27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Clin Cancer Res 9: 3389-3396, 2003. (Pubitemid 37082734)
24. Masaki T, Shiratori Y, Rengifo W, et al: Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37: 534-543, 2003. (Pubitemid 36258774)
25. Chang JG, Chen YJ, Perng LI, et al: Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract. Eur J Cancer 35: 647-651, 1999.
26. Yang MY, Liu TC, Chang JG, Lin PM and Lin SF: JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood 101: 3205-3211, 2003.
27. Yeh KY, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC and Lin CC: Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol 23: 1001-1007, 2003.
28. Herman JG, Graff JR, Myöhänen, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
29. Andrecht S, Kolbus A, Hartenstein B, Schorpp-Kistner M and Angel P: Cell cycle promoting activity of JunB through cyclin A activation. J Bio Chem 277: 35961-35968, 2002.
30. Passegué E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U and Wagner EF: Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage. Cell 104: 21-32, 2001. (Pubitemid 32144969)
31. Mathas S, Hinz M, Anagnostopoulos I, et al: Aberrantly expressed C-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB. EMBO J 21: 4104-4113, 2002. (Pubitemid 34857442)
32. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD and Whitteaker SJ: Amplification and overexpression of JunB is associated with primary cutaneous T-cell lymphomas. Blood 101: 1513-1519, 2003. (Pubitemid 36182528)
33. Wang H, Birkenbach M and Hart J: Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis 21: 1313-1317, 2000. (Pubitemid 30455989)
34. Choo KB, Huang CJ, Chen CM, Han CP and Au LC: Jun-B oncogene aberrations in cervical cancer cell lines. Cancer Lett 93: 249-253, 1995.
35. Bamberger AM, Milde-Langosch K, Rossing E, Goemann C and Loning T: Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 127: 545-550, 2001. (Pubitemid 32757488)
36. Neyns B, Katesuwanasing, Vermeij J, et al: Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium. Oncogene 12: 1247-1257, 1996.